Sociedad Argentina de Hematología

ISSN 2250-8309

FORMULARIOS

Declaración de Conflictos de Interés

Cesión de Derechos de Autor


Se solicita enviar ambos formularios a: revista@sah.org.ar

 

 

 

Hematology Journal

Regulations

The journal HEMATOLOGÍA is the official body of communication of the Argentinean Society of Hematology (SAH). The printed version of HEMATOLOGÍA is distributed free of charge to members of the Argentinean Society of Hematology and to medical and university libraries. The electronic version is completely free of access.

This journal publishes hematology-related works, provided they meet the scientific and technical requirements set by Editorial Board. The journal releases 3 ordinary issues per year plus one or two extraordinary supplements.

After their evaluation, the journal publishes original articles related to scientific research, reviews, pediatrics in hematology, new drugs in hematology, laboratory, clinical cases and images in hematology that have not been published in another magazine or media.

All original works undergo arbitration by two judges, members of the Scientific Advisory Committee, professionals with recognized expertise on the matter that will remain anonymous in a double-blind process of evaluation (the author does not know the identity of the reviewer, nor the reviewer the identity of the author).

Within a month of submission, the judges will issue the work as: approved without modifications, approved with modifications or rejected. This decision is final. In case of disagreement between the judges, a third one will be summoned.

The journal accepts the publication of works from non-Spanish speaking authors in English.

Currently, the sections of the journal HEMATOLOGÍA are:

  1. Original articles
  2. My opinion
  3. Anatomo-clinic discussion of the hematology fellowships
  4. Editorial
  5. Updates and/or revisions
  6. Pediatric Hematology
  7. New Drugs in Hematology
  8. Brief communications
  9. Laboratory
  10. History of Hematology
  11. Case reports, clinical problem resolution
  12. Imaging in Hematology
  13. Letters to the Editor

1) Original articles submitted for publication must be unprecedented and must not have been submitted to any other publication.

Simultaneous submission should also be avoided as long as the article is under review from the Journal HEMATOLOGÍA.
Works should be typed on Word format, double-spaced, Times New Roman, size 12 typeface, with 3-cm wide margins and a maximum of 4 000 words, including tables and bibliography. Tables and figure legends must go in separate pages from the main text.

Works must be developed according to the following arrangement: a) Title (in Spanish and English); b) Abstract (in Spanish and English); c) Introduction; d) Materials and Methods; e) Results; f) Discussion; g) Literature cited.
Title: Write the title in capital letters without abbreviations; it should be brief and precise. In a separate line, list the authors separated by commas: the complete last name first, and then the initial of the name. Then, detail the name of the institution (without abbreviations), the place where the work was carried out, the address and P.O. box, the name of the source country and the author’s e-mail.

Abstract: Works should include an Abstract in Spanish that must provide a concise idea of each of the items mentioned above. It should not exceed 400 words. Include a footnote of 3 to 5 keywords in the Abstract, using terms of the Medical Subjects Headings from Index Medicus.

You should also include an Abstract in English, specifying the complete title of the work and 3 to 5 keywords.

Introduction: It is a brief summary of the state of the art of the subject to be addressed and the objectives of the work.
Materials and Methods: Clearly describe the study population used in the work (control and patient groups), the ethodology used and the statistics methods employed in the result assessment. In this section you must include a statement indicating the approval of the institution’s Ethics Committee or relevant authority. In addition, you should also state that a written informed consent was obtained from every patient and that the study protocol was performed according to the ethics standards of the 1975 Declaration of Helsinki.

Results: The results must be clearly oexpressed in quantitative form, using numerical values (using standard international units), tables and/or graphics. Tables should be clear and presented on individual pages. Tables exceeding the size of a page of the Journal will not be accepted. Abbreviations and symbols must be specified in the text or on table footnotes.
Discussion: This section analyses the results and facts directly related to them, the relationship between the results and the objectives initially stated and their comparison with previous established knowledge.

References: The authors are responsible for checking the accuracy and integrity of the references. Only include the references mentioned in the article; they must be in numerical order and consecutively arranged. You must list the names of the authors first, separated by commas: last name first, followed by the initials of the first name. If the authors are more than 6, only mention the first 3 followed by the acronym «et.al.». Then, write the title of the article followed by the abbreviated name of the journal according to the «Index Medicus»; the year of issue, semicolon, Volume number, colon, first page, dash, last page. Eg. Kaldor JM, Day EN, Clarke EA et al. Leukemia following Hodgkin’s disease. N Engl. J Med 1990; 322:7-13.

If the reference is a book, indicate: the name of the author/s, chapter title, book title, editor/s, publication year, page numbers separated by dash, issue number if this is not the first edition, publishing house and city. Eg. Hughes TP and Goidman JM. Chronic myeloid leukemia. Hematology: Basic Principles and Practice. R. Hoffman, El Benz, Sj Shatill, B Ftirie y EJCoben 1991, p 854-869. Churchill Livingstone, Edinburgh.

Quotes must be referenced in the text between parentheses and using superscript format.

2) The section “My opinion” expresses the opinion of an expert about a controversial issue commissioned by the Editorial Board.

Disagreement with this opinion can be expressed through the section “Letters to the Editor”. This section has a maximum of 3 000 words. You must use the graphic format of the original article.

3) The anatomo-clinic discussions of the hematology fellowships must follow the same graphic format and guidelines as the original articles.

4) Editorials are commissioned by the Editorial Board. The title and text should be similar to that of a monograph, not exceeding 2 000 words with a maximum of 5 literature references, indicating the name of the author, his/her address, P.O. box and e-mail address.

5) Updates and/or revisions must follow the graphic format of the original articles. It should not exceed 5 000 words.

6) The section “Pediatric Hematology” reviews topics related to hematology and clinical cases in children. It must follow the graphic format of the original articles.

7) The section “New drugs in Hematology” is an update on new drugs used in this specialty. It is commissioned by the Editorial Board.

Extension should not exceed 3 000 words and it must follow the graphic format of the original articles.

8) The section “Brief communications” must follow the same graphic format as the original articles. It should not exceed 2 000 words and its abstract should not be longer than 200 words.

9) The section “Laboratory in Hematology” presents a data sheet of a trial used in Hematology laboratories. It is commissioned by the Editorial Board. It must present an introduction, the basis for the trial, pre-analytical and analytical characteristics, reference values and its clinical interest, and up to 4 literature references. Extension should not exceed 3 000 pages. It must follow the same graphic format as the original articles.

10) The section “History of Hematology” must follow the same graphic format as the original articles and is intended to divulge the development of Hematology in Argentina. Its extension should not exceed 4 000 words.

11) The section “Case reports, clinical problem resolution” should not exceed 8 literature references. It must follow the same graphic format as the original articles.

12) “Imaging in Hematology” consists of high quality, in color, photographic material, intended to present diverse issues. It should not exceed 1 000 words and it must be developed in the following order: title, concise text, image, name of the author/s. You can add up to 4 literature references. It must follow the same graphic format as the original articles.

13) The section “Letters to the Editor” features opinions on clinical conditions and experiences that might or might not relate to the articles published in the Journal, with a critical, objective and/or educational criterion, accepting the right to rebuttal if it is an opinion about a published work. Extension should not exceed 1 000 words (and up to 4 literature references).

Conflicts of interest Authors are exclusively responsible for the content, statements and authorship of the published articles, and they must include a written statement clarifying if there is any conflict of interest involved. All participants must include their disclosure in a footnote. From its first edition in 2013, all submissions to be published in the Journal HEMATOLOGÍA must include a paragraph at the end of the work where the declaration of conflicts of interest is specified according to the attached model.

You are NOT allowed to send the work that was submitted to HEMATOLOGÍA to another journal or publication.
The adapted model of the standards for conflicts of interest proposed by the SAH Board of Directors is based on that of the American Society of Hematology and bears the same format as several prestigious journals of our specialty. We refer to all current activities and those carried out last year.

We recognize different categories of conflict as detailed:

  1. Employee
  2. Consultant
  3. Share ownership
  4. Research Funds for our own studies (the standard does NOT include multicenter, national or international phase II to IV research protocols)
  5. Conference fee (Speaker)
  6. Advisory Board member

Transfer of copyright All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology.

In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication.

Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted.

Authors should send an electronic version to both e-mails listed below:

Argentinean Society of Hematology, Editorial Board of HEMATOLOGÍA
Julián Álvarez 146 - 1414 - CABA - Argentina
E-mail: sah@sah.org.ar /// revista@sah.org.ar

 

SOCIEDAD ARGENTINA DE HEMATOLOGÍA
Julián Alvarez 146 - Ciudad Autónoma de Bs As - Argentina
(54-11) 4855-2452 / 2485

http://www.sah.org.ar/revista/

Formulario